Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Heat Biologics Inc (HTBX)

Heat Biologics Inc (HTBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,092
  • Shares Outstanding, K 22,800
  • Annual Sales, $ 3,050 K
  • Annual Income, $ -20,020 K
  • 60-Month Beta 0.32
  • Price/Sales 18.29
  • Price/Cash Flow N/A
  • Price/Book 1.25
Trade HTBX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.34
  • Number of Estimates 3
  • High Estimate -0.28
  • Low Estimate -0.43
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.22 +31.99%
on 01/04/21
7.37 -6.51%
on 01/19/21
+1.15 (+20.03%)
since 12/22/20
3-Month
5.22 +31.99%
on 01/04/21
8.89 -22.50%
on 11/02/20
-1.37 (-16.59%)
since 10/22/20
52-Week
1.37 +404.76%
on 02/27/20
30.10 -77.11%
on 07/21/20
+4.77 (+224.85%)
since 01/22/20

Most Recent Stories

More News
Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021

DURHAM, NC / ACCESSWIRE / January 20, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...

HTBX : 6.89 (-2.82%)
Heat Biologics Commences Manufacturing Process for ZVX-60

, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today...

HTBX : 6.89 (-2.82%)
Heat Biologics Promotes William L. Ostrander to Chief Financial Officer

DURHAM, NC / ACCESSWIRE / January 11, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...

HTBX : 6.89 (-2.82%)
Heat Biologics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

DURHAM, NC / ACCESSWIRE / January 8, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...

HTBX : 6.89 (-2.82%)
Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences

, /PRNewswire/ -- Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma...

CNSP : 2.04 (+0.99%)
SIOX : 2.80 (-2.78%)
HTBX : 6.89 (-2.82%)
BMY : 64.56 (+0.59%)
GILD : 66.94 (-0.06%)
Thinking about buying stock in Veru Inc, Neovasc, Sio Gene Therapies, Tilray, or Heat Biologics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VERU, NVCN, SIOX, TLRY, and HTBX.

SIOX : 2.80 (-2.78%)
TLRY : 18.02 (+0.56%)
HTBX : 6.89 (-2.82%)
NVCN : 1.3000 (+7.44%)
VERU : 9.02 (+1.01%)
Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19

Preparations for manufacturing underway

HTBX : 6.89 (-2.82%)
Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NEOS, ONCT, HTBX, FCEL, and CIDM.

CIDM : 1.3800 (+5.34%)
FCEL : 18.13 (+4.86%)
NEOS : 0.8437 (+2.38%)
ONCT : 5.50 (-0.54%)
HTBX : 6.89 (-2.82%)
Heat Biologics Provides Business Update

DURHAM, NC / ACCESSWIRE / December 10, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...

HTBX : 6.89 (-2.82%)
Heat Biologics Provides Business Update

DURHAM, NC / ACCESSWIRE / December 10, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...

HTBX : 6.89 (-2.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell...

See More

Key Turning Points

3rd Resistance Point 7.43
2nd Resistance Point 7.28
1st Resistance Point 7.09
Last Price 6.89
1st Support Level 6.75
2nd Support Level 6.60
3rd Support Level 6.41

See More

52-Week High 30.10
Fibonacci 61.8% 19.12
Fibonacci 50% 15.73
Fibonacci 38.2% 12.34
Last Price 6.89
52-Week Low 1.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar